Characteristic | 2014, N (%) | 2015, N (%) | 2016, N (%) | 2017, N (%) | Total N (%) |
---|---|---|---|---|---|
Total TB cases of all Forms | 138 | 354 | 473 | 588 | 1553 |
Age group | |||||
  < 15 | 26 (18.8) | 92 (26.0) | 135 (28.5) | 177 (30.1) | 430 (27.7) |
 15–29 | 50 (36.2) | 107 (30.2) | 141 (29.8) | 152 (25.9) | 450 (29.0) |
 30–44 | 39 (28.3) | 87 (24.6) | 107 (22.6) | 132 (22.4) | 365 (23.5) |
 45–59 | 15 (10.9) | 43 (12.1) | 46 (9.7) | 79 (13.4) | 183 (11.8) |
  > = 60 | 6 (4.3) | 23 (6.5) | 39 (8.3) | 44 (7.5) | 112 (7.2) |
 Not documented | 3 (2.2) | 2 (0.6) | 4 (1.0) | 4 (0.7) | 13 (0.8) |
Mean age, years | 28.0 | 27.1 | 26.8 | 27.0 | 27.2 |
Sex | |||||
 Male | 80 (58.0) | 193 (54.5) | 247 (52.2) | 330 (56.1) | 850 (54.7) |
 Female | 57 (41.3) | 160 (45.2) | 222 (46.9) | 251 (42.7) | 690 (44.4) |
 Not documented | 1 (0.7) | 1 (0.3) | 4 (0.9) | 7 (1.2) | 13 (0.8) |
Type of TB | |||||
 PTB | 106 (76.8) | 279 (78.8) | 334 (70.6) | 389 (66.2) | 1108 (71.3) |
 EPTB | 32 (23.2) | 73 (20.6) | 134 (28.3) | 192 (32.7) | 431 (27.8) |
 Not documented | 0 | 2 (0.6) | 5 (1.1) | 7 (1.1) | 14 (0.9) |
Type of TB by diagnostic category | |||||
 PTB+ | 47 (34.0) | 162 (45.8) | 216 (45.7) | 252 (42.9) | 677 (43.6) |
 Clinically diagnosed PTBa | 59 (42.8) | 117 (33.1) | 118 (25.0) | 137 (23.3) | 431 (27.7) |
 EPTB | 32 (23.2) | 73 (20.6) | 134 (28.3) | 192 (32.6) | 431 (27.8) |
 Not documented | 0 | 2 (0.5) | 5 (1.0) | 7 (1.2) | 14 (0.9) |
TB patient by previous treatment history: | |||||
 New and relapseb | 137 (99.3) | 347 (98.0) | 462 (97.7) | 581 (98.8) | 1527 (98.3) |
 Treatment after Failure | 0 | 0 | 1 (0.2) | 1 (0.2) | 2 (0.1) |
 Lost to Follow up to Treatment | 1 (0.7) | 3 (0.8) | 5 (1.1) | 4 (0.6) | 13 (0.8) |
 Others | 0 | 1 (0.3) | 2 (0.4) | 1 (0.2) | 4 (0.3) |
 Not documented | 0 | 3 (0.8) | 3 (0.6) | 1 (0.2) | 7 (0.5) |
New and relapse PTB patients: | 105 (76.6) | 276 (80.4) | 328 (71.0) | 384 (66.1) | 1093 (71.6) |
 Bacteriologically confirmed cases: | 46 (43.8) | 161 (58.3) | 210 (64.0) | 249 (64.8) | 666 (60.9) |
 Clinically diagnosed cases: | 59 (56.2) | 115 (41.7) | 118 (36.0) | 135 (35.2) | 427 (39.1) |
HIV status | |||||
 Positive | 10 (8.6) | 48 (15.3) | 50 (13.2) | 57 (10.9) | 165 (10.6) |
 Negative | 106 (91.4) | 265 (84.7) | 329 (86.8) | 464 (89.1) | 1164 (75.0) |
 Not documented | 22 (15.9) | 41 (11.6) | 94 (26.6) | 67 (11.4) | 224 (14.4) |
ART initiation | |||||
 Yes | 4 (40.0) | 44 (91.7) | 38 (76.0) | 48 (84.2) | 134 (81.2) |
 No | 6 (60.0) | 4 (8.3) | 12 (24.0) | 9 (15.8) | 31 (18.8) |
TB cases by refugee areas | |||||
 Shire | 21 (15.2) | 28 (7.9) | 26 (5.5) | 28 (4.8) | 103 (6.6) |
 Afar | 0 | 0 | 6 (1.3) | 47 (8.0) | 53 (3.4) |
 Gambella | 43 (31.2) | 159 (44.9) | 288 (60.9) | 368 (62.6) | 858 (55.2) |
 Mizan | 2 (1.4) | 30 (8.5) | 18 (3.8) | 29 (4.9) | 79 (5.1) |
 Asossa | 14 (10.1) | 29 (8.2) | 16 (3.4) | 14 (2.4) | 73 (4.7) |
 Jijiga | 45 (32.6) | 42 (11.9) | 45 (9.5) | 34 (5.8) | 166 (10.7) |
 Dollo Ado | 13 (9.4) | 66 (18.6) | 74 (15.6) | 68 (11.6) | 221 (14.2) |